Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 41

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05459701Phase 4Completed
Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes
PrincipalinvestigatorStart date: 2022-05-01

Research Network

Collaboration Network

8 collaborators·8 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Damanhour University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sonia Caprio, MD

Yale University

Moderately Similar
9 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver Disease
Similarity Score30%

Samuel Klein, MD

Washington University School of Medicine

Moderately Similar
30 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Similarity Score30%

Yasmin Essam, Bachlor

Damanhour University

Related
1 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2

Worked with same sponsors:

Rehab WeridaUniversity of Alexandria
Collaborated on 1 trial
Similarity Score24%

Rehab H Werida, Ass Prof.

Damanhour University

Related
9 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver Disease

Worked with same sponsors:

Rehab WeridaUniversity of Alexandria
Collaborated on 1 trial
Similarity Score24%

Paolo Bonato, PhD

Spaulding Rehabilitation Hospital

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2
Similarity Score15%

Rémi Rabasa-Lhoret

Institut de Recherches Cliniques de Montreal

Related
16 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2
Similarity Score15%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score15%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2
Similarity Score15%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2
Similarity Score15%

Glen P Kenny, PhD

University of Ottawa

Related
18 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05459701Phase 4PrincipalInvestigator

Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)

Nonalcoholic Fatty Liver DiseaseType 2 Diabetes
Completed

All 1 trials loaded